Therefore, the major goals of PEX in TTP are the removal of the antibodies against ADAMTS-13 and the supplementation of ADAMTS-13 via FFP, preventing further thrombi formation. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.